Ya I think the plan was to start by end of year 2015 but all the regulatory organizations don't move as fast as Terry Norchi does (of course). Now that things are beginning to be rolling on the trial side ARTH is all set.
Doing the human trials where they are, for the CE mark, should give them the data required to get it approved quickly through the FDA (relative to doing the human trial in the U.S. first).
and yes 21money21, I thought we'd be over $1 by now too. Multiple dollars in a couple years.
News 
Market Data 
Discover 
AI
